Biochemical aspect of HMG CoA reductase inhibitors
- 31 December 1989
- journal article
- review article
- Published by Elsevier in Advances in Enzyme Regulation
- Vol. 28, 53-64
- https://doi.org/10.1016/0065-2571(89)90063-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Isolation of Compactin (A Hypocholestrolemic Metabolite) from a New Source: Penicillium cyclopiumJournal of Natural Products, 1986
- Monacolin M, a new inhibitor of cholesterol biosynthesis.The Journal of Antibiotics, 1986
- Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber.The Journal of Antibiotics, 1985
- Dihydromonacolin L and monacolin X. new metabolites those inhibit cholesterol biosynthesis.The Journal of Antibiotics, 1985
- Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B)The Journal of Antibiotics, 1983
- Dihydrocompactin,a new potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase from Penicillium citrinum.The Journal of Antibiotics, 1981
- Dihydromevinolin,a potent hypocholesterolemic metabolite produced by Aspergillus terreus.The Journal of Antibiotics, 1981
- Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase.The Journal of Antibiotics, 1980
- Monacolin K, a new hypocholesterolemic agent produced by a Monascus species.The Journal of Antibiotics, 1979
- ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogensis produced by Penicillium citrinum.The Journal of Antibiotics, 1976